MedTech Dive January 25, 2024
Nick Paul Taylor

The reorganization establishes new divisions at the Office of Strategic Partnerships and Technology Innovation to account for its growth since 2019.

Dive Brief:

  • The Food and Drug Administration has elevated and expanded an office that handles activities including medical device cybersecurity and digital health.
  • Effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has become a “super office.” The reorganization creates new divisions and programs at the OST to account for its growth since 2019 and raise the profile of digital health work.
  • The five offices housed in the OST will lead the FDA’s medical device resilient supply chain and shortages program, drive the development of voluntary consensus standards and work on new approaches to digital health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Cybersecurity, FDA, Govt Agencies, Health IT, Medical Devices, Supply Chain, Technology
Related Articles:
Opinion: Three former FDA officials: Here’s what Trump and his nominees need to know
Inflammatix Scores FDA Approval for Precision Infection Test
FDA Approves Spravato as Monotherapy for Major Depressive Disorder
A next-generation form of chemotherapy wins FDA approval
AstraZeneca, Daiichi’s Enhertu successor gets first FDA OK in breast cancer

Share This Article